VANCENASE Drug Patent Profile
✉ Email this page to a colleague
When do Vancenase patents expire, and when can generic versions of Vancenase launch?
Vancenase is a drug marketed by Schering and is included in three NDAs.
The generic ingredient in VANCENASE is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.
Summary for VANCENASE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 2 |
Patent Applications: | 4,697 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VANCENASE at DailyMed |
Recent Clinical Trials for VANCENASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fred Hutchinson Cancer Research Center | Phase 2 |
Merck Sharp & Dohme Corp. | Phase 3 |
US Patents and Regulatory Information for VANCENASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | VANCENASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018521-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | VANCENASE AQ | beclomethasone dipropionate monohydrate | SPRAY, METERED;NASAL | 019589-001 | Dec 23, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | VANCENASE AQ | beclomethasone dipropionate monohydrate | SPRAY, METERED;NASAL | 020469-001 | Jun 26, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VANCENASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | VANCENASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018521-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | VANCENASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018521-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | VANCENASE | beclomethasone dipropionate | AEROSOL, METERED;NASAL | 018521-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VANCENASE
See the table below for patents covering VANCENASE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Philippines | 13620 | STEROIDAL AEROSOL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | ⤷ Try a Trial |
Germany | 2320111 | ⤷ Try a Trial | |
Austria | 352973 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |